跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,247 条关于
“MEDIPAL Holdings Corporation”
全部
11,247
临床试验
5,523
药物
762
机构
2,450
资讯
2,512
去年
MEDIPAL Holdings and JCR Pharmaceuticals Partner on Novel GM2 Gangliosidosis Therapy JR-479
5天前
MEDIPAL and JCR Dose First Patient in Global Phase I/II Trial of JR-446 for Sanfilippo Syndrome Type B
11个月前
JR-446 Receives Japanese Orphan Drug Designation for Rare Sanfilippo Syndrome Type B
去年
FDA Grants Orphan Drug Designation to JR-446 for Rare Neurological Disorder MPS IIIB
7个月前
JCR Pharmaceuticals Presents Promising Blood-Brain Barrier Data for Rare Disease Therapies at WORLDSymposium 2026
去年
SeaStar Medical Focuses on Hyperinflammation Therapies for Critical Illnesses
去年
Journey Medical's Emrosi Receives FDA Approval for Rosacea Treatment
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
Geron Corporation Advances in Myeloid Hematologic Malignancies Treatment
去年
PDS Biotech Updates Phase 3 VERSATILE-003 Trial Design for HPV16-Positive HNSCC
第 1 页，共 252 页
上一页
下一页
